PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer — Stella

Recruiting

Back to Prostate Cancer trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Hoag Memorial Hospital Presbyterian, Irvine, California

Key details

Phase

Safety & dosing

Sponsor

Hoag Memorial Hospital Presbyterian

Enrollment target

~184 participants

Started

February 2021

Primary completion

July 2022

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Sex

Male only

Last updated July 2021

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov